Welcome back to Audioboards, everyone! Today, we are taking a deep, high-yield dive into the backbone of ambulatory care: USPSTF Grade A and B Recommendations.
As residents, it is easy to get caught up in acute inpatient management, but mastering outpatient preventive health is where we change long-term disease trajectories. Knowing when to start a screening is essential—but on board exams and in real-world clinics, knowing when to stop screening is just as critical to prevent over diagnosis, over treatment, and procedural harm.
So, let’s run through these recommendations systematically by organ system, covering the initiation age, frequency, and exact stopping criteria.
Let’s start with cardiovascular risk reduction and vascular screening.
Hypertension: Screen all adults 18 and older with office blood pressure measurement (Grade A). Crucially, obtain out-of-office blood pressure measurements (ABPM or home logs) before starting pharmacotherapy to confirm the diagnosis.
When to stop: There is no upper age limit to stop screening for hypertension, as long as control aligns with the patient's goals of care and overall health status.
Lipids & Statins for Primary Prevention: Initiate a low-to-moderate dose statin for primary prevention in adults aged 40 to 75 with no history of CVD, who have more than 1 CVD risk factors (dyslipidemia, diabetes, HTN, smoking), and an estimated 10-year CVD risk of greater than equal to 10%(Grade B).
When to stop / upper limit: Evidence for initiating statins for primary prevention in adults 75 and older is an I statement meaning insufficient evidence.
Diabetes & Prediabetes: Screen adults aged 35 to 70 who are overweight or obese (Grade B).
When to stop: Screening stops at age 70, unless additional clinical risk factors warrant individualized assessment.
Abdominal Aortic Aneurysm (AAA): One-time screening with abdominal ultrasonography in men aged 65 to 75 who have ever smoked (greater than equal to 100 cigarettes in a lifetime) (Grade B).
When to stop: Do not screen men past age 75 (or non-smokers/women routinely). It is strictly a one-time screen between ages 65 and 75.
Next we have Oncology, where stopping criteria are heavily tested.
Colorectal Cancer:
Ages 45 to 49: Grade B.
Ages 50 to 75: Grade A.
When to stop: Age 75. For adults aged 76 to 85, routine screening is a Grade C (individualized decision based on prior screening history, life expectancy, and overall health). Stop all screening at age 85.
Strategies: Colonoscopy every 10 years, annual FIT, stool DNA-FIT every 1–3 years, or CT colonography/flexible sigmoidoscopy every 5 years.
Cervical Cancer:
Ages 21 to 29: Cytology (Pap) every 3 years (Grade A).
Ages 30 to 65: Pap every 3 years, hrHPV testing every 5 years, or hrHPV + Pap co-testing every 5 years (Grade A).
When to stop: Age 65, provided the patient has had adequate prior negative screening (e.g., 3 consecutive negative Pap tests or 2 consecutive negative HPV tests within the past 10 years, with the most recent test within 5 years) and is not at high risk. Also stop after a total hysterectomy (with removal of the cervix) for benign indications with no history of CIN 2+.
Note: Do not screen under 21 or post-hysterectomy for benign disease with cervical removal.
Breast Cancer: Biennial (every 2 years) screening mammography for women aged 40 to 74 (Grade B). For patients with personal/family history suggestive of BRCA1/2 mutations, perform risk assessments; if positive, refer for genetic counseling and testing (Grade B). For high-risk, low-adverse-risk women greater than35, offer risk-reducing medications like tamoxifen, raloxifene, or aromatase inhibitors (Grade B).
When to stop: Age 74. Evidence for screening mammography in women 75 and older is currently classified as an "I statement" (insufficient evidence).
Lung Cancer: Annual low-dose CT (LDCT) in adults aged 50 to 80 who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years (Grade B).
When to stop: Discontinue screening once the patient reaches age 81, or if they have been quit for >15 years, or if they develop a health problem that substantially limits life expectancy or the ability/willingness to undergo curative lung surgery.
Next, infectious disease screening guidelines across the lifespan.
HIV: Screen all individuals aged 15 to 65, as well as anyone outside that age range who is at elevated risk, plus all pregnant persons (Grade A).
When to stop: Routine universal screening stops at age 65, unless ongoing high-risk behaviors persist.
Hepatitis C (HCV): Screen all adults aged 18 to 79 with anti-HCV antibody testing (Grade B).
When to stop: Universal screening stops at age 79.
Hepatitis B (HBV): Screen non-pregnant adolescents and adults at high risk (e.g., endemic geographic origin, HIV+, IVDU) (Grade B), and screen all pregnant persons at their first prenatal visit (Grade A).
STIs (Chlamydia & Gonorrhea): Screen all sexually active females 24 years or younger, and females age greater than 25 at elevated risk (Grade B).
When to stop: Routine screening in average-risk females stops at age 24.
Latent Tuberculosis (LTBI): Screen asymptomatic adults at increased risk (e.g., foreign-born individuals from high-prevalence countries, congregate living) using IGRA or TST (Grade B).
Let's talk about mental health, bone density, and when to halt specific screenings.
Anxiety: Screen adults aged less than 64 years, including pregnant and postpartum persons (Grade B). Also screen children/adolescents aged 8 to 18 (Grade B).
When to stop: Screenings for anxiety carry a formal USPSTF recommendation up to age 64. (Screening in adults greater than 65 is currently an "I statement").
Depression: Screen all adults including pregnant/postpartum women and older adults (Grade B). There is no upper age limit to stop.
Osteoporosis: Screen for osteoporosis with dual-energy X-ray absorptiometry (DXA) in all women 65 and older (Grade B). Also screen postmenopausal women younger than 65 if their clinical risk assessment places them at an equivalent risk to a 65-year-old white woman with no additional risk factors (Grade B).
When to stop: The USPSTF does not set a strict upper age limit to stop osteoporosis screening, but clinical judgment applies based on life expectancy and fracture risk management goals.
Fall Prevention: Exercise interventions for community-dwelling adults 65 and older who are at increased risk for falls (Grade B).
Lastly, let's wrap up with perinatal prevention windows.
Preeclampsia: Low-dose aspirin (81 mg/day) starting after 12 weeks of gestation for high-risk patients (Grade B).
Neural Tube Defects: All individuals planning or capable of pregnancy should take daily 0.4 to 0.8 mg (400–800 mcg) of folic acid supplementation (Grade A).
Gestational Diabetes: Screen pregnant persons at or after 24 weeks of gestation (Grade B).
Asymptomatic Bacteriuria: Screen with urine culture at 12–16 weeks gestation or at first prenatal visit (Grade B).
Rh Incompatibility: Blood typing/antibody testing at first visit (Grade A); repeat at 24–28 weeks for unsensitized Rh-negative patients (Grade B).
That completes our comprehensive walk-through of USPSTF Grade A and B guidelines, including start times, intervals, and stopping criteria.
Remember: stopping screening is just as much of an active medical decision as starting one. When a patient reaches 75 for colon cancer or 65 for cervical cancer with a clean history, taking those items off their health maintenance list protects them from unnecessary interventions.
Thanks for listening to AudioBoards. Stay tuned for more educational content in our next episode! The views and opinions expressed on the AudioBoards Podcast do not necessarily reflect those of our employers. This podcast is for educational purposes only and should not be used to diagnose or treat any medical conditions. It is not a substitute for professional medical advice. Always consult a qualified, board-certified healthcare provider for any medical concern.
.png)
